Research
Popular workout supplement may blunt heart benefits of exercise in females, Dalhousie study finds
Dalhousie research suggests a popular nitrate supplement may hinder key exercise-driven heart improvements in females, highlighting overlooked sex differences and raising questions about long-term cardiovascular effects. Read more.
Featured News
Friday, May 1, 2026
By better mimicking native conditions on campus, a multidisciplinary team unlocked seed production in an endangered aquatic plant, strengthening long‑term research, student training, and future discoveries.
DalSolutions: How Dalhousie is helping to transform Nova Scotia into a global hub for carbon removal
Tuesday, April 28, 2026
Dalhousie researchers are tackling a critical climate question—whether the ocean can safely remove carbon dioxide at scale—while positioning Nova Scotia as a global leader in carbon removal innovation.
Wednesday, February 25, 2026
Dalhousie is helping to prepare Canada’s defence community for AI-supported command and control, including fast developing Arctic surveillance scenarios, by simulating how humans and intelligent systems make decisions together under pressure.
Archives - Research
Friday, December 2, 2022
PhD candidate Cristiane Maucoski receives prestigious national award for work evaluating the effectiveness of tools used to harden the more than 800 million white composite fillings dentists place each year.
Friday, December 2, 2022
Where should you live? A new Dal study that ranks Canadian cities based on indicators of environmental quality could help you decide.
Thursday, November 24, 2022
Last night’s 20th annual Discovery Awards, co-presented by Dalhousie, was a moment to celebrate university innovators who are inspiring the next generation of Nova Scotian scientists.
Thursday, November 24, 2022
With global market demand for plant-based and alternative proteins projected to reach approximately US$143 billion by 2035, this Dal prof is exploring how Atlantic Canada can scale up its production.
Tuesday, November 22, 2022
A pair of post-doctoral fellows in Dal's Department of Microbiology and Immunology have shown that an existing drug used to treat cancer and other illnesses also holds the promise of effectively treating people infected with the virus that causes COVID-19.